These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16091220)

  • 1. Vaginal microbicides: a novel approach to preventing sexual transmission of HIV.
    Doncel G; Mauck C
    Curr HIV/AIDS Rep; 2004 Apr; 1(1):25-32. PubMed ID: 16091220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update on Vaginal Microbicides.
    Mauck C; Doncel G
    Curr Infect Dis Rep; 2001 Dec; 3(6):561-568. PubMed ID: 11722815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update.
    Lard-Whiteford SL; Matecka D; O'Rear JJ; Yuen IS; Litterst C; Reichelderfer P;
    J Acquir Immune Defic Syndr; 2004 May; 36(1):541-52. PubMed ID: 15097296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.
    Madan RP; Keller MJ; Herold BC
    Curr Opin Infect Dis; 2006 Feb; 19(1):49-54. PubMed ID: 16374218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbicides: putting women in control.
    Forbes A
    WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections.
    Ndesendo VM; Pillay V; Choonara YE; Buchmann E; Bayever DN; Meyer LC
    AAPS PharmSciTech; 2008; 9(2):505-20. PubMed ID: 18431651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
    Nikolic DS; Garcia E; Piguet V
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of HIV microbicides: challenges and opportunities.
    Garg AB; Nuttall J; Romano J
    Antivir Chem Chemother; 2009; 19(4):143-50. PubMed ID: 19374141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D; Mayer KH
    J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of microbicides in the prevention of HIV and sexually transmitted diseases - a review.
    Ramachandran R; Shanmughavel P
    Curr HIV Res; 2009 May; 7(3):279-86. PubMed ID: 19442123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of topical microbicides to prevent the sexual transmission of HIV.
    Buckheit RW; Watson KM; Morrow KM; Ham AS
    Antiviral Res; 2010 Jan; 85(1):142-58. PubMed ID: 19874851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.
    Bentley ME; Morrow KM; Fullem A; Chesney MA; Horton SD; Rosenberg Z; Mayer KH
    Fam Plann Perspect; 2000; 32(4):184-8. PubMed ID: 10942354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbicides for prevention of transmission of sexually transmitted diseases.
    Howett MK; Kuhl JP
    Curr Pharm Des; 2005; 11(29):3731-46. PubMed ID: 16305508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
    Roberts L; Liebenberg L; Barnabas S; Passmore JA
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):441-9. PubMed ID: 22429786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Antiretroviral Microbicides for HIV Prevention.
    Scott Y; Dezzutti CS
    AIDS Rev; 2016; 18(3):145-150. PubMed ID: 27438574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the vaginal delivery route for antiretrovirals in HIV prevention.
    Ferguson LM; Rohan LC
    Ther Deliv; 2011 Dec; 2(12):1535-50. PubMed ID: 22468220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.